Trial Profile
Phase I trial of intravenous pyridoxamine [Pyridorin] for the treatment of acute kidney injury
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2015
Price :
$35
*
At a glance
- Drugs Pyridoxamine (Primary)
- Indications Acute kidney injury
- Focus Adverse reactions
- 30 Mar 2015 New trial record
- 24 Mar 2015 According to a media release, NephroGenex is in pre-Investigational New Drug discussions with the FDA and expects to file an IND.